introduction to clinical immunity phcl 505 dr: wael h mansy; md assistant professor college of...

32
Mechanisms of protection against infection and disease. Primarily they can be divided into two major categories: 1.non-specific (innate) 2.specific (adaptive) What is the immunity?

Upload: jayson-mosley

Post on 20-Jan-2018

216 views

Category:

Documents


0 download

DESCRIPTION

Overview of the Immune System Immune System Innate (Nonspecific) 1 st line of defense Cellular ComponentsHumoral Components Adaptive (Specific) 2 nd line of defense Protects/re-exposure Cellular ComponentsHumoral Components Interactions between the two systems

TRANSCRIPT

Page 1: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Mechanisms of protection against infection and disease.

Primarily they can be divided into two major categories:

1. non-specific (innate)

2. specific (adaptive)

What is the immunity?

Page 2: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Overview of the Immune System

Immune System

Innate(Nonspecific)

1st line of defense

Adaptive(Specific)

2nd line of defenseProtects/re-exposure

Cellular Components Humoral Components Cellular Components Humoral Components

Interactions between the two systems

Page 3: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Non-specific Immunity (innate) Specific Immunity (adaptive)

Its response is antigen-independent.

Its response is antigen-dependent.

There is immediate response. There is a lag time between exposure and maximal response.

It is not antigen-specific. It is antigen-specific.

Exposure does not result in induction of memory cells.

Exposure results in induction of memory cells.

Some of its cellular components or their products may aid specific

immunity

Some of its products may help non-specific immunity.

Comparison of Innate and Adaptive Immunity

Page 4: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Cells of the Immune System

Immune System

Myeloid Cells Lymphoid Cells

Granulocytic Monocytic T cells B cells

NeutrophilsBasophils

Eosinophils

MacrophagesKupffer cells

Dendritic cells

Helper cellsSuppressor cellsCytotoxic cells

Plasma cells

NK cells

Page 5: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Development of the Immune System

ery pl

mye

neu mφ

lym

nk

thy

CD8+

CD4+

TH2

TH1

Page 6: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Infection and Immunity Balance

infection immunity

Bolus of infection x virulenceimmunity

Disease =

Page 7: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

• Beneficial:

• Protection from Invaders• Elimination of Altered Self.

• Detrimental:

• Discomfort and collateral damage (inflammation)• Damage to self (hypersensitivity or autoimmunity)

Effects of the Immune System

Page 8: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Innate (Nonspecific) Immunity

Page 9: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Overview of the Immune System

Immune System

Innate(Nonspecific)

Adaptive(Specific)

Cellular Components Humoral Components Cellular Components Humoral Components

Page 10: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Innate Host Defenses Against Infection

• Anatomical barriers– Mechanical factors– Chemical factors– Biological factors

• Humoral components– Complement– Coagulation system– Cytokines

• Cellular components– Neutrophils– Monocytes and macrophages– NK cells– Eosinophils

Page 11: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Anatomical Barriers - Mechanical Factors

System or Organ Cell type Mechanism

Skin Squamous epithelium Physical barrierDesquamation

Mucous Membranes Non-ciliated epithelium (e.g. GI tract)

Peristalsis

Ciliated epithelium (e.g. respiratory tract)

Mucociliary elevator

Epithelium (e.g. nasopharynx)

Flushing action of tears, saliva, mucus, urine

Page 12: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Anatomical Barriers - Chemical Factors

System or Organ Component Mechanism

Skin Sweat Anti-microbial fatty acids

Mucous Membranes HCl (parietal cells)Tears and saliva

Low pHLysozyme and phospholipase A

Defensins (respiratory & GI tract)

Antimicrobial

Sufactants (lung) Opsonin

Page 13: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Anatomical Barriers - Biological Factors

System or Organ Component Mechanism

Skin and mucous membranes

Normal flora Antimicrobial substancesCompetition for nutrients and colonization

Page 14: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Humoral ComponentsComponent Mechanism

Complement Lysis of bacteria and some virusesOpsoninIncrease in vascular permeabilityRecruitment and activation of phagocytic cells

Coagulation system Increase vascular permeabilityRecruitment of phagocytic cellsΒ-lysin from platelets – a cationic detergent

Lactoferrin and transferrin

Compete with bacteria for iron

Lysozyme Breaks down bacterial cell walls

Cytokines Various effects

Page 15: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Cellular Components

Cell Functions

Neutrophils Phagocytosis and intracellular killingInflammation and tissue damage

Macrophages Phagocytosis and intracellular killingExtracellular killing of infected or altered self targetsTissue repairAntigen presentation for specific immune response

NK and LAK cells Killing of virus-infected and altered self targets

Eosinophils Killing of certain parasites

Page 16: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Phagocytosisand

Intracellular Killing

Page 17: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

• Characteristic nucleus, cytoplasm

• Granules

• CD 66 membrane marker

Phagocytes - Neutrophils (PNMs)

Page 18: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

primary granules

contain cationic proteins, lysozyme, defensins, elastase and myeloperoxidase

secondary granules

contain lysozyme, NADPH oxidase components, lactoferrin and B12-binding protein

azurophilic; characteristic of young neutrophils;

specific for mature neutrophils

Characteristics of Neutrophil Granules

Page 19: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

• Characteristic nucleus

• Lysosomes

• CD14 membrane marker

Phagocytes - Macrophages

Page 20: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Phagocyte Response to Infection

•Chemotaxis–N-formyl methionine-containing

peptides–Clotting system peptides–Complement products–Cytokines released by tissue

macrophages

•Phagocyte response–Vascular adherence–Diapedesis–Chemotaxis–Activation–Phagocytosis and killing

Page 21: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Attachment via Receptors:

IgG FcR

Scavenger R

Complement R

Toll-like R

Initiation of Phagocytosis

Page 22: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Phagocytosis

• Attachment

•Pseudopod extension

•Phagosome formation

•Granule fusion

•Phagolysosome formation

Page 23: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

*Toxic compounds – Superoxide anion (O2 -), Hydrogen peroxide (H2O2), Singlet oxygen (1O2) and Hydroxyl radical (OH*)

Respiratory BurstOxygen-Dependent Myeloperoxidase-Independent

Reactions

Pentose-P + NADPHG-6-P-dehydrogenase

Glucose +NADP+

NADPH oxidaseCytochrome b558

NADP++ O2-NADPH + O2

Superoxide dismutase H2O2 + 1O22O2- + 2H+

2O2- + H2O2

OH* + OH- + 1O2

Page 24: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Respiratory Burst

Oxygen-Dependent Myeloperoxidase-Dependent Reactions

myeloperoxidaseOCl- + H2OH2O2 + Cl-

2OCl- + H2O1O2 + Cl-+ H2O

Toxic compounds – Hypochlorous acid (OCl-), and Singlet oxygen (1O2)

Page 25: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Respiratory Burst

Detoxification Reactions

H2O2 + O2

Superoxide dismutase

H2O + O2

Catalase2O2

- + 2H+

2 H2O2

Page 26: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Effector Molecule Function

Oxygen-Independent Killing in the Phagolysosome

Cationic proteins (cathepsin) Damage to microbial membranes

Lysozyme Hydrolyses mucopeptides in the cell wall

Lactoferrin Deprives pathogens of iron

Hydrolytic enzymes (proteases) Digests killed organisms

Page 27: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Summary of Intracellular Killing Pathways

Intracellular Killing

OxygenDependent

OxygenIndependent

MyleoperoxidaseDependent

MyleoperoxidaseIndependent

Page 28: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Nitric Oxide Dependent KillingIFNγ

TNF

TNF

Nitric OxideNitric Oxide

Page 29: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Non-specific Killer Cells

NK and LAK cells

Killer cell

Activated macrophages

Eosinophils

They all kill foreign and altered self

targets

Page 30: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Natural Killer (NK) cells

also known as large granular lymphocytes (LGL)

kill virus-infected or malignant cells

identified by the presence of CD56 & CD16 and absence of CD3

activated by IL2 and IFN-γ to become LAK cells

Page 31: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

Lymphokine Activated Killer (LAK) cell

IL2

IFNIFN

IL2

kills malignant

cells

kills transformed

and malignant cells

Page 32: Introduction To Clinical Immunity PHCL 505 Dr: Wael H Mansy; MD Assistant Professor College of Pharmacy

K Cells

morphologically undefined

have Fc receptor

recognize antibody coated targets

could be NK cells (IgG), macrophages (IgG), eosinophils (IgE) or other cells (IgG)